Barclays’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-96,200
Closed -$934K 7358
2017
Q2
$934K Buy
96,200
+23,500
+32% +$236K ﹤0.01% 2948
2017
Q1
$771K Buy
72,700
+20,500
+39% +$217K ﹤0.01% 2969
2016
Q4
$466K Buy
52,200
+16,100
+45% +$163K ﹤0.01% 3434
2016
Q3
$435K Sell
36,100
-10,600
-23% -$143K ﹤0.01% 3343
2016
Q2
$607K Buy
46,700
+25,100
+116% +$233K ﹤0.01% 3046
2016
Q1
$108K Sell
21,600
-35,100
-62% -$185K ﹤0.01% 4297
2015
Q4
$284K Buy
56,700
+4,000
+8% +$24.1K ﹤0.01% 3633
2015
Q3
$316K Buy
52,700
+2,500
+5% +$15.2K ﹤0.01% 3761
2015
Q2
$301K Buy
50,200
+2,900
+6% +$17.1K ﹤0.01% 3869
2015
Q1
$189K Sell
47,300
-500
-1% -$2.78K ﹤0.01% 4391
2014
Q4
$239K Buy
47,800
+6,000
+14% +$31.5K ﹤0.01% 4499
2014
Q3
$251K Buy
41,800
+11,900
+40% +$102K ﹤0.01% 4538
2014
Q2
$239K Buy
29,900
+2,900
+11% +$25.1K ﹤0.01% 4661
2014
Q1
$243K Sell
27,000
-42,700
-61% -$401K ﹤0.01% 4604
2013
Q4
$419K Buy
69,700
+11,700
+20% +$70.7K ﹤0.01% 4278
2013
Q3
$348K Buy
58,000
+13,300
+30% +$99.6K ﹤0.01% 4493
2013
Q2
$284K Buy
+44,700
New +$329K ﹤0.01% 4836

Other funds holding SSRI

Barclays's SSRI Position: Q3 2017 in Review

Barclays sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 13,982 shares — an estimated $136K sold.

Barclays first reported a position in SSRI in Q2 2013 and held it in 17 quarters. The position peaked at $402K in Q2 2013. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

  • Barclays reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
  • Barclays sold 13,982 Silver Standard Resources shares in Q3 2017, an estimated $136K.
  • Barclays first reported a position in Silver Standard Resources in Q2 2013 and held it in 17 quarters.
  • Barclays's Silver Standard Resources position peaked at $402K in Q2 2013.
  • 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.